Denali therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Denali therapeutics Contact Number

Denali Contact

2 hours ago Denalitherapeutics.com Show details

©2020 Denali Therapeutics 161 Oyster Point Boulevard, South San Francisco, CA 94080

Category: Contact SupportShow more

Denali Home

5 hours ago Denalitherapeutics.com Show details

Denali Therapeutics is dedicated to defeating neurodegenerative diseases through rigorous therapeutic discovery and development. Follow the link and fill out our centralized contact form and we will get in touch with you shortly. Contact Us . CONTACT US. 161 Oyster Point Blvd- South San Francisco, CA 94080

Category: Home PhoneShow more

Denali Therapeutics Inc. Company Profile South San

7 hours ago Dnb.com Show details

(650) 866-8548Denali Therapeutics Inc. is located in South San Francisco, CA, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. Denali Therapeutics Inc. has 216 total employees across all of its locations and generates $335.66 million in sales (USD). There are 3 companies in the Denali Therapeutics Inc. corporate family.

Employees: 216
Phone: (650) 866-8548
Location: 161 Oyster Point Blvd, South San Francisco, 94080-2042, CA

Category: Contact NumberShow more

Denali Therapeutics Email Formats & Employee Phones

6 hours ago Signalhire.com Show details

650-866-8548Its headquarters is located at South San Francisco, California, USA. The number of employees ranges from 250 to 500. The annual revenue of Denali Therapeutics varies between 100M and 500M. Total funding of the company - $597M. To connect with Denali Therapeutics employee register on SignalHire.

Denali Therapeutics Employees Size: 200-500 employees
SIC Code: 2834, 2836
Phone Number: 650-866-8548

Category: Phone NumberShow more

Denali Therapeutics Crunchbase Company Profile & …

9 hours ago Crunchbase.com Show details

Therapeutics. Headquarters Regions San Francisco Bay Area, West Coast, Western US. Founded Date May 14, 2015. Founders Alexander Schuth, Marc Lavigne, Ryan Watts. Operating Status Active. Last Funding Type Series B. Also Known As Denali. Legal Name Denali Therapeutics Inc. Stock Symbol FRA:4DN.

Founders: Alex Schuth, Marc Tessier-Lavigne

Category: Contact NumberShow more

Denali Therapeutics Company Profile Office Locations

6 hours ago Craft.co Show details

Denali Therapeutics has 261 employees at their 1 location and $335.66 M in annual revenue in FY 2020. See insights on Denali Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Category: Contact NumberShow more

Denali Customer Service & Support Denali

2 hours ago Denaliai.com Show details

Denali customer service and support experts have the answers to all of your integrated IT solutions and services questions. Connet with one via email or phone.

Category: Customer Service, Support NumberShow more

Denali Therapeutics Flagship Pioneering

5 hours ago Flagshippioneering.com Show details

09.04.2019Latest Press from Denali Therapeutics. Denali Therapeutics Announces First Patient Dosed In Phase 1b Study Of DNL151 For Parkinson’s Disease And Launch Of Its Engage Parkinson’s Website 09.04.2019; Denali Therapeutics Announces That Its Partner Sanofi has Commenced Dosing of DNL758 in a Phase 1 Study 08.05.2019

Category: Contact NumberShow more

Denali Therapeutics Inc. (DNLI) Company Profile & Facts

5 hours ago Finance.yahoo.com Show details

See the company profile for Denali Therapeutics Inc. (DNLI) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and

Category: Contact NumberShow more

Denali Center Foundationhealthpartners

7 hours ago Foundationhealth.org Show details

Denali Center is recognized as one of the finest skilled nursing facilities in the Pacific Northwest. Opened in 1994, Denali Center is a 90-bed comprehensive short- and long-term care facility located next to Fairbanks Memorial Hospital, and accessed through …

Category: Contact NumberShow more

Denali Therapeutics Announces Upcoming Presentations on

2 hours ago Globenewswire.com Show details

(650) 452-2747Investor Relations Contact: Media Contacts: Laura Hansen, Ph.D. Vice President, Investor Relations (650) 452-2747 [email protected]: Lizzie Hyland (646) 495-2706

1. Author: Denali Therapeutics Inc.

Category: Contact NumberShow more

DNL201 ALZFORUM

4 hours ago Alzforum.org Show details

Overview. Name: DNL201 Therapy Type: Small Molecule Target Type: Inflammation , Other Condition(s): Parkinson's Disease U.S. FDA Status: Parkinson's Disease (Inactive) Company: Biogen, Denali Therapeutics Inc. Background. DNL201 is an orally available, brain-penetrant inhibitor of the leucine-rich repeat kinase 2 (LRRK2). It was being …

Category: Contact NumberShow more

Denali Therapeutics ZIP 94080, NAICS 541714, SIC 8731

8 hours ago Siccode.com Show details

Business Overview "Denali Therapeutics" of South San Francisco, CA 94080 operates primarily in SIC Code 8731 - Commercial Physical and Biological Research and NAICS Code 541714 - Research and Development in Biotechnology (except Nanobiotechnology).Denali Therapeutics is a small-sized business with medium revenue, that is established in its industry.

Category: Contact NumberShow more

EX10.1

4 hours ago Sec.gov Show details

4. Status Reports.The parties mutually agree that Denali’s and DBH’s obligations under Sections 4.1, 4.7.2, 4.9 and 5.3 of the LCA and Sections 4.2 and 4.4.1 of the GIPL shall be limited to a written report in the form attached hereto as Appendix A which will be provided to F-star Therapeutics (with a copy being sent by email to [email protected]) [***].

Category: Contact NumberShow more

Denali Borough, AK

Just Now Denaliborough.org Show details

Denali Borough Landfill. Cantwell Transfer Station. Healy Transfer Station. Land Management. E911 Uniform Addressing and Street Naming. New Street Name Proposal Form. Street Name Map Comments. Trails and Transportation Planning. Finance Department.

Category: Contact NumberShow more

Denali Therapeutics Announces Progression and Expansion of

6 hours ago Globenewswire.com Show details

(650) 452-2747About Denali Therapeutics. Investor Relations Contact: Laura Hansen, Ph.D. Vice President, Investor Relations (650) 452-2747 [email protected] Media Contacts: Lizzie Hyland (646) 495-2706

Category: Contact NumberShow more

About Denali Company Profile Denali

7 hours ago Denaliai.com Show details

Board of Directors. Denali is a family-owned, privately-held company. Mohamad (Alex) Daher is the Chairman and co-founder of 3MD, Inc. a family-owned portfolio of businesses based in Redmond, Washington that includes Denali Advanced Integration, a global technology integrator. Mohamad has been a life-long entrepreneur with a proven track-record

Category: Contact NumberShow more

Companies with 'D' EIN, Address and Contact Page 5

Just Now Eintaxid.com Show details

(650) 866-8548EIN Number: 46-3872213 Address: 161 Oyster Point Blvd., South San Francisco, California Doing Business As: Denali Therapeutics Inc Phone: (650) 866-8548

Category: Contact SupportShow more

Denali Therapeutics LinkedIn

2 hours ago Linkedin.com Show details

Denali Therapeutics is dedicated to defeating neurodegenerative diseases by breaking through historical barriers in scientific research and clinical development in order to deliver safe and

Category: Contact NumberShow more

Todd Logan Senior Scientist Denali Therapeutics

8 hours ago Zoominfo.com Show details

View Todd Logan's business profile as Senior Scientist at Denali Therapeutics. Find contact's direct phone number, email address, work history, and more.

Category: Contact NumberShow more

Denali Therapeutics Inc Company Profile and News

9 hours ago Bloomberg.com Show details

Company profile page for Denali Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information

Category: Contact NumberShow more

Do Hedge Funds Love Denali Therapeutics Inc. (DNLI

2 hours ago Insidermonkey.com Show details

Of the funds tracked by Insider Monkey, Casdin Capital, managed by Eli Casdin, holds the number one position in Denali Therapeutics Inc. (NASDAQ:DNLI). Casdin Capital has a $85.8 million position

1. Author: Debasis Saha

Category: Contact NumberShow more

Denali Water Solutions Team

6 hours ago Denaliwater.com Show details

Denali Water professionals have hundreds of years of experience in residuals management, organic compost, land application, transportation, environmental permitting, dredging, dewatering, Class A processing, lime stabilization, drying, gasification, …

Category: Contact NumberShow more

Hong Lin Principal Scientist Denali Therapeutics

2 hours ago Apollo.io Show details

View Hong Lin's business profile as Principal Scientist at Denali Therapeutics. Find Hong's email address, mobile number, work history, and more.

Category: Contact NumberShow more

Denali Therapeutics: Number of Employees 20162021 DNLI

6 hours ago Macrotrends.net Show details

Interactive chart of Denali Therapeutics (DNLI) annual worldwide employee count from 2016 to 2021. Denali Therapeutics total number of employees in 2020 was 291, a 11.49% increase from 2019.; Denali Therapeutics total number of employees in 2019 was 261, a 45.81% increase from 2018.; Denali Therapeutics total number of employees in 2018 was 179, a 37.69% …

Category: Contact NumberShow more

Denali Therapeutics Inc. (DNLI) May Report Negative

8 hours ago Finance.yahoo.com Show details

For the last reported quarter, it was expected that Denali Therapeutics Inc. Would post a loss of $0.37 per share when it actually produced a loss of $0.50, delivering a surprise of …

Category: Contact NumberShow more

Denali Therapeutics Funding, Financials, Valuation

8 hours ago Crunchbase.com Show details

Funding. Denali Therapeutics has raised a total of $347M in funding over 4 rounds. Their latest funding was raised on Aug 25, 2016 from a Series B round. Denali Therapeutics is registered under the ticker FRA:4DN . Denali Therapeutics is funded by 8 investors. Baillie Gifford and ARCH Venture Partners are the most recent investors.

Category: Contact NumberShow more

Denali Therapeutics Reports Third Quarter 2021 Financial

1 hours ago Biospace.com Show details

Denali Therapeutics Inc., a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier for neurodegenerative diseases, reported financial results for the third quarter ended September 30, 2021, and provided business highlights. (study number NCT05006352). The Phase 1b study is a

Category: Contact NumberShow more

Denali Therapeutics Reports Third Quarter 2021 Financial

7 hours ago Finance.yahoo.com Show details

J.P. Morgan Healthcare Conference, January 10-13, 2022. Third Quarter 2021 Financial Results. For the three months ended September 30, 2021, Denali reported a net loss of $84.6 million compared

Category: Contact NumberShow more

DNLI Denali Therapeutics Inc. • BioPharmCatalyst

5 hours ago Biopharmcatalyst.com Show details

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ:DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases, today reported financial results for the third quarter ended September 30, 2021, and provided …

Category: Contact NumberShow more

Denali Therapeutics unveils bloodbrain barrier delivery

8 hours ago Cen.acs.org Show details

Denali’s transport vehicle is a twist on the “Trojan horse” approach to drug delivery, which has been around since the 1980s, says University of Washington professor William A. Banks.

Category: Contact NumberShow more

Kathryn Monroe's email & phone number Associate Director

9 hours ago Signalhire.com Show details

View Kathryn Monroe's email address: [email protected] & phone: +1-480-xxx-xx25's profile as Associate Director and Principal Scientist at Denali Therapeutics, located in San Francisco, California. Find contacts: direct phone number, email address, work experience.

Category: Phone NumberShow more

Form 4 Denali Therapeutics Inc. For: Dec 28 Filed by

4 hours ago Streetinsider.com Show details

FORM 4. UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP. Filed pursuant to Section 16 (a) of the Securities Exchange Act of

Category: Contact NumberShow more

Insider Selling: Denali Therapeutics Inc. (NASDAQ:DNLI

9 hours ago Marketbeat.com Show details

Denali Therapeutics Inc. (NASDAQ:DNLI) CEO Ryan J. Watts sold 5,007 shares of the company's stock in a transaction dated Wednesday, January 5th. The stock was sold at an average price of $44.78, for a total value of $224,213.46. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.. Shares of Denali Therapeutics stock …

Category: Contact NumberShow more

Biogen and Denali to Collaborate on LRRK2 Program for

6 hours ago Investors.biogen.com Show details

617 679 4945BIOGEN MEDIA CONTACT: Biogen Inc. David Caouette + 617 679 4945 [email protected] DENALI THERAPEUTICS CONTACT: Morgan Warners (GPG) + 202 295 0124 [email protected] BIOGEN INVESTOR CONTACT: Biogen Inc. Joe Mara +781 464 2442 [email protected]

Category: Contact NumberShow more

Denali Therapeutics Reports First Quarter 2021 Financial

Just Now Bloomberg.com Show details

021-05-03Denali Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights 55 ) Weighted average number of shares outstanding, 120,884,665 102,419,718 basic and diluted (1

Category: Contact NumberShow more

Biogen and Denali to Collaborate on LRRK2 Program for

5 hours ago Finance.yahoo.com Show details

617 679 4945Denali disclaims any obligation to update any forward-looking statements, except as required by law.BIOGEN MEDIA CONTACT: Biogen Inc. David Caouette \+ 617 679 4945 [email protected]

Category: Contact NumberShow more

Where Do Hedge Funds Stand On Denali Therapeutics Inc. (DNLI)?

6 hours ago Finance.yahoo.com Show details

The number of bullish hedge fund bets inched up by 6 lately. Denali Therapeutics Inc. (NASDAQ:DNLI) was in 26 hedge funds' portfolios at the end of March. The all time high for this statistic was

Category: Contact NumberShow more

Morgan Stanley Lowers Denali Therapeutics (NASDAQ:DNLI

6 hours ago Marketbeat.com Show details

Denali Therapeutics has a 52 week low of $41.10 and a 52 week high of $83.98. The company has a market capitalization of $5.37 billion, a price-to-earnings ratio of 314.24 and a beta of 1.75. The firm's fifty day moving average price is $47.22 and its 200 day moving average price is $53.11. Denali Therapeutics (NASDAQ:DNLI) last posted its

Category: Contact NumberShow more

Denali Therapeutics Announces Positive Interim Data from

9 hours ago Marketscreener.com Show details

SOUTH SAN FRANCISCO, Calif., July 25, 2021 - Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases, today announced additional positive interim data from a Phase 1/2 study evaluating ETV:IDS (DNL310), an investigational …

Category: Contact NumberShow more

MidAfternoon Market Update: Nasdaq Dips 250 Points

2 hours ago Markets.businessinsider.com Show details

2 days ago · The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 64,359,400 cases with around 866,890 deaths. Denali Therapeutics NewsMORE. Contact Us!

Category: Contact NumberShow more

DNLI: Denali Therapeutics Inc Stock Price, Quote and

2 hours ago Cnbc.com Show details

Denali Therapeutics Inc. is a biopharmaceutical company. The Company is focused on the discovery and development of therapies for patients with …

Category: Contact NumberShow more

Kirk Henne at Denali Therapeutics AroundDeal B2B

7 hours ago Arounddeal.com Show details

Description. Denali Therapeutics Inc. (“Denali”) is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that

Category: Contact NumberShow more

Denali Therapeutics : Announces Progression and Expansion

9 hours ago Marketscreener.com Show details

SOUTH SAN FRANCISCO, Calif., Jan. 10, 2022 -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases, today announced program progress and expected milestones for 2022, which Chief Executive …

Category: Contact NumberShow more

Denali Therapeutics Reports Third Quarter 2021 Financial

1 hours ago Marketwatch.com Show details

021-11-04Press Release Denali Therapeutics Reports Third Quarter 2021 Financial Results and Business Highlights Published: Nov. 4, 2021 at 4:01 p.m. ET

Category: Contact NumberShow more

Denali Therapeutics Inc (DNLI) is up 0.46% in a Week

7 hours ago Investorsobserver.com Show details

Denali Therapeutics Inc is near the top in its industry group according to InvestorsObserver.DNLI gets an overall rating of 50. That means it scores higher than 50 percent of stocks. Denali Therapeutics Inc gets a 77 rank in the Biotechnology industry. Biotechnology is number 93 out of 148 industries.

Category: Contact NumberShow more

Denali Therapeutics Inc. (DNLI) Stock Price, News, Quote

7 hours ago Finance.yahoo.com Show details

Find the latest Denali Therapeutics Inc. (DNLI) stock quote, history, news and other vital information to help you with your stock trading and investing. Contact Us; Advertisement

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What is Denali Therapeutics?

Denali Therapeutics is a biotechnology company. Denali Therapeutics is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, ALS and others.

Does dendenali Therapeutics (dnli) stock deliver strong earnings and revenue surprises?

Denali Therapeutics Inc. (DNLI) delivered earnings and revenue surprises of -35.29% and -78.45%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Who owns Denali?

Denali is a family-owned, privately-held company. Mohammad (Alex) Daher is the Chairman and co-founder of 3MD, Inc. a family-owned portfolio of businesses based in Redmond, Washington that includes Denali Advanced Integration, a global technology integrator.

Is Denali center a skilled nursing facility?

Denali Center is recognized as one of the finest skilled nursing facilities in the Pacific Northwest. Opened in 1994, Denali Center is a 90-bed comprehensive short- and long-term care facility located next to Fairbanks Memorial Hospital, and accessed through a corridor connecting the two buildings.

Popular Brands

Daikin
Denso
Demant
Dsv
Dlf
Dbs
Dsm
Dana